Drug Trial Radar · NCT02584257
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Last checked: Nov 20, 2026Latest source record: Dec 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
217
Actual
Start
Apr 2016
Primary completion
Aug 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- Lupin, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 22, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.
Conditions
- Mild Persistent Asthma
Interventions
methacholine chlorideOther
placebo ProAir HFADrug
ProAir HFADrug
Lupin albuterol HFA MDIDrug
placebo Lupin albuterol HFA MDIDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-dose PC20 Concentration After Receiving Differing Doses of Test, Reference, or PlaceboTime frame: Post-dose at Visits 2-6 of the study, a total of approximately 4 weeks.
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Investigational Research Center Site #110
Huntington Beach, California
Investigational Research Center Site #114
Mission Viejo, California
Investigational Research Center Site #113
Rolling Hills Estates, California
Investigational Research Center Site #112
San Diego, California
Investigational Research Center Site #116
San Jose, California
Investigational Research Center Site #106
Tallahassee, Florida
Investigational Research Center Site #109
Baltimore, Maryland
Investigational Research Center Site #105
Bethesda, Maryland
Investigational Research Center Site #103
North Dartmouth, Massachusetts
Investigational Research Center Site #108
St Louis, Missouri
Investigational Research Center Site #115
Bellevue, Nebraska
Investigational Research Center Site #104
Skillman, New Jersey
Investigational Research Center Site #102
Raleigh, North Carolina
Investigational Research Center Site #111
Cincinnati, Ohio
Investigational Research Center Site #118
Tulsa, Oklahoma
Investigational Research Center Site #101
Medford, Oregon
Investigational Research Center Site #107
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.